Skip to content
Clinical Trials – home
LithuaniaBack to Lithuania

Clinical trials in Kaunas

175 clinical trials in Kaunas, Lithuania across 3 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

LithuaniaOur site in LithuaniaKlinikiniai-Tyrimai.lt(opens in a new tab)
Kaunas at a glance
175
clinical trials
  • Research sites3
Type of trial
Recruitment status
Quick filters

175 trials in Kaunas

Open in trial search
Countries:LithuaniaLithuania
  • Participants:18–64 years · 65+ years
  • Substances:LUNSEKIMIG
  • Sponsor:Sanofi-Aventis Recherche & Developpement
Countries:LithuaniaLithuania
  • Participants:18–64 years · 65+ years
  • Sponsor:Eli Lilly & Co.
Countries:LithuaniaLithuania
  • Participants:18–64 years
  • Sponsor:Zenas Biopharma (USA) LLC
Countries:LithuaniaLithuania
  • Participants:18–64 years · 65+ years
  • Substances:Barzolvolimab
  • Sponsor:Celldex Therapeutics Inc.
Countries:LithuaniaLithuania
  • Participants:18–64 years · 65+ years
  • Substances:Barzolvolimab
  • Sponsor:Celldex Therapeutics Inc.
Countries:LithuaniaLithuania
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Duvakitug
  • Sponsor:Sanofi-Aventis Recherche & Developpement
Countries:LithuaniaLithuania
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Duvakitug
  • Sponsor:Sanofi-Aventis Recherche & Developpement
Countries:LithuaniaLithuania
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Duvakitug
  • Sponsor:Sanofi-Aventis Recherche & Developpement
Countries:LithuaniaLithuania
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Duvakitug
  • Sponsor:Sanofi-Aventis Recherche & Developpement
Countries:LithuaniaLithuania
  • Participants:18–64 years · 65+ years
  • Substances:Bi 690517
  • Sponsor:Boehringer Ingelheim Espana S.A.
Countries:LithuaniaLithuania
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Bi 1291583
  • Sponsor:Boehringer Ingelheim Espana S.A.
Countries:LithuaniaLithuania
  • Participants:18–64 years · 65+ years
  • Substances:Tulisokibart
  • Sponsor:Merck Sharp & Dohme LLC

Other cities in Lithuania

The busiest research cities in the country

All 10 cities in Lithuania

Clinical research in Kaunas

What the registry says about research in the country

01 Oncology Research

Groundbreaking studies focusing on acute myeloid leukemia, various types of lung cancer, and bladder cancer treatments. Research includes innovative combination therapies and novel drug applications.

  • Advanced NSCLC Treatments
  • Leukemia Therapies
  • Bladder Cancer Interventions

Emphasis on both early-stage and metastatic disease management.

02 Autoimmune Disorders

Clinical investigations targeting systemic sclerosis, ulcerative colitis, and Crohn's disease. Studies evaluate new biological therapies and disease-modifying treatments.

  • Inflammatory Bowel Diseases
  • Systemic Lupus Erythematosus
  • Rheumatoid Arthritis

Focus on improving quality of life and disease management.

03 Preventive Medicine

Research into preventive healthcare including influenza vaccines and contraceptive methods. Studies examine both pediatric and adult populations.

  • Vaccine Development
  • Contraceptive Technologies
  • Immunization Studies

Emphasis on safety and long-term effectiveness.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).